Droperidol Flashcards
Droperidol Mechanism of Action
• Droperidol blocks dopamine and alpha receptors centrally, resulting in sedation, reduced agitation and a state of mental detachment.
Droperidol Indications
Patients aged greater than or equal to 12 years with agitated delirium causing a mild to moderate risk to safety, when olanzapine has not been administered
or is ineffective.
Droperidol Contraindications
Known Severe Allergy
Droperidol Cautions
Parkinson’s disease. There is a risk of worsening the movement disorder associated with Parkinson’s disease.
Concurrent administration of other sedatives. This will increase and prolong the effects.
Intoxication. This will increase and prolong the effects.
Elderly and/or frail. These will increase and prolong the effects.
Droperidol Use in pregnancy/breastfeeding
Safety has not been demonstrated. The likelihood of a pregnant or breastfeeding patient requiring droperidol is very low, but it should be administered if indicated.
Droperidol Dose
10 mg IM or IV.
7.5mg appropriate for most patients - IM volume issue
• Reduce the dose to 5 mg if the patient is frail.
• The dose may be repeated once after 20 minutes.
Droperidol Administration
IM or IV undiluted Lateral thigh preferred Otherwise Lateral upper arm. IV over 1-2 minutes IV and IM administration have same onset, don't delay for IV access
Droperidol Adverse effects
Hypotension - particularly if IV dose is given quickly
Droperidol Onset of effect
5-10 minutes
Droperidol duration of effect
4-6 hours
Droperidol Preparation
2.5mg/1ml
Droperidol Pharmacokinetics
- Droperidol is predominantly metabolised in the liver with metabolites being excreted in the urine.
- There are no significant effects from liver impairment on acute administration.
Droperidol Common interactions
- Intoxication. Droperidol will have increased sedative effects if the patient is intoxicated with alcohol or has taken recreational drugs.
- Sedative drugs. Concurrent administration with other sedative drugs (such as olanzapine or midazolam) will result in an increased sedative effect.
Droperidol Additional information
• Droperidol has been reported to prolong the QT interval. This generally involved repeated and/or high doses and one or two doses are safe, even if the
patient is known to have a prolonged QT interval.
• Droperidol may cause dyskinesia (abnormal, uncoordinated and involuntary movements) but this is unusual following one or two doses.
Droperidol acts on which receptors?
Dopamine
Muscarinic
Histamine
A-1